Modification and qualification of a stirred single-use bioreactor for the improved expansion of human mesenchymal stem cells at benchtop scale

Valentin Jossen, Carmen Schirmaier, Jacqueline Herrmann, Alexander Tappe, Dieter Eibl, Ann Siehoff, Christian van den Bos, Regine Eibl

Pharmaceutical Bioprocessing · 2014 · 30 citations · 16 references

DOIFull text

Open access

Concepts

Abstract

Background: To improve cultivation conditions for human bone-marrow-derived mesenchymal stem cells, we redesigned the commercially available UniVessel ® SU bioreactor using results obtained from computational fluid dynamics.The goal was to produce ≥1 × 10 9 cells and to achieve expansion factors ≥30.Screening studies suggested that microcarrier solid fractions of at least 0.3% are required to reach the appropriate cell densities.Results: The fluid flow pattern found in the most promising modification (#2) was altered by increasing the impeller blade angle and lowering the off-bottom clearance.As a result, the maximum required specific power input was reduced by a factor of 2.2-4.6,depending on the microcarrier concentration, and peak cell densities were 3.4-times higher than in the standard version.Conclusion: The peak cell number of nearly 1.1 × 10 9 cells (expansion factor = 35), which was achieved in our low-serum cultivations, indicates an improvement in the redesigned UniVessel ® SU configuration for bone marrow-derived mesenchymal stem cell expansions.

References

16